Welcome to our dedicated page for Aflac news (Ticker: AFL), a resource for investors and traders seeking the latest updates and insights on Aflac stock.
Aflac Incorporated (NYSE: AFL), a global leader in supplemental insurance, provides critical financial protection through innovative products in the U.S. and Japan. This news hub offers investors and stakeholders centralized access to verified corporate developments, strategic initiatives, and market updates.
Track official announcements, product launches, and leadership changes alongside analyses of Aflac's voluntary benefits expansion and technology partnerships. Our curated collection includes earnings reports, regulatory filings, and coverage of community-focused programs like pediatric cancer research support.
Discover updates on Aflac's core insurance offerings including accident, dental, and cancer coverage innovations. Stay informed about operational milestones in both the Japanese and American markets through primary-source documents and contextual reporting.
Bookmark this page for real-time updates on AFL's financial performance, dividend declarations, and industry leadership in supplemental health solutions. Verify all information through direct links to SEC filings and company-issued communications.
Aflac Incorporated (NYSE: AFL) reported first-quarter 2023 results with total revenues of $4.8 billion, down from $5.2 billion year-over-year. Net earnings rose to $1.2 billion or $1.94 per diluted share, compared to $1.0 billion or $1.60 per share last year. Adjusted earnings increased to $953 million, up 1.2%, with adjusted earnings per diluted share at $1.55, reflecting a 7.6% increase. However, net earned premiums in Aflac Japan fell 17.3%, while Aflac U.S. saw a modest increase of 1.1%. The company declared a $0.42 dividend for Q2 2023 and announced a $700 million share repurchase plan. Aflac maintains a solid capital position despite challenges from currency exchange rates.